These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 3332705

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
    Moittie D, Simonet M, Veron M.
    Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
    [Abstract] [Full Text] [Related]

  • 3. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL, Monroy E, García O, Vaca S.
    Rev Latinoam Microbiol; 1998 May; 40(3-4):128-34. PubMed ID: 10932741
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC, Barry AL.
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [Abstract] [Full Text] [Related]

  • 6. Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity.
    Hardin TC, Butler SC, Ross S, Wakeford JH, Jorgensen JH.
    Pharmacotherapy; 1994 Mar; 14(2):147-52. PubMed ID: 8197032
    [Abstract] [Full Text] [Related]

  • 7. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 8. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H.
    Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
    [Abstract] [Full Text] [Related]

  • 9. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
    Villar HE, Jugo MB, Fernández-Lausi A, Farinati AE.
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
    [Abstract] [Full Text] [Related]

  • 10. [In vitro and in vivo activity of a combination of clavulanic acid and amoxicillin against Klebsiella pneumoniae producing extended broad-spectrum betalactamase (CTX-1, SHV-3, SHV-4)].
    Migueres ML, Ronco E, Guenounou M, Philippon A.
    Pathol Biol (Paris); 1989 May; 37(5):397-401. PubMed ID: 2674869
    [Abstract] [Full Text] [Related]

  • 11. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 12. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
    Mascellino MT, Prignano G, Lorenzi A, Iegri F, Martorano E, Catania S, Ginanni Corradini S.
    Boll Ist Sieroter Milan; 1984 Mar; 63(5):447-52. PubMed ID: 6335660
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
    Marre R, Schulz E.
    Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae.
    Fuchs PC, Barry AL, Pfaller MA, Hardy DJ, McLaughlin JC, Gerlach EH.
    Diagn Microbiol Infect Dis; 1993 Jul; 17(2):171-5. PubMed ID: 8243040
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibilities of Escherichia coli and Klebsiella spp. to ampicillin-sulbactam and amoxicillin-clavulanic acid.
    Kacmaz B, Sultan N.
    Jpn J Infect Dis; 2007 Jul; 60(4):227-9. PubMed ID: 17642541
    [Abstract] [Full Text] [Related]

  • 16. Activity of amoxycillin/clavulanate against beta-lactamase-producing Escherichia coli and Klebsiella spp.
    Roy C, Segura C, Torrellas A, Reig R, Teruel D, Hermida M.
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():41-7. PubMed ID: 2691485
    [Abstract] [Full Text] [Related]

  • 17. [Development of resistance in bacteria interacting with subinhibitory antibiotic concentrations].
    Cokça F, Altay G.
    Mikrobiyol Bul; 1992 Oct; 26(4):333-7. PubMed ID: 1435363
    [Abstract] [Full Text] [Related]

  • 18. Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producing Enterobacteriaceae.
    Siu LK, Cheng WL, Ho PL, Ng WS, Chau PY, Lo JY.
    APMIS; 1998 Sep; 106(9):917-20. PubMed ID: 9808419
    [Abstract] [Full Text] [Related]

  • 19. [Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
    Cisterna R, Fresnadillo MJ, García-Rodríguez JA, Gobernado M, Martín R, Perea E, Picazo J.
    Rev Esp Quimioter; 1998 Sep; 11(3):245-50. PubMed ID: 9795311
    [Abstract] [Full Text] [Related]

  • 20. [Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers].
    Etesse-Carsenti H, Garraffo R, Bernard E, de Salvador F, Pradier C, Durant J, Mondain V, Drugeon HB, Dellamonica P.
    Pathol Biol (Paris); 1991 Dec; 39(10):972-7. PubMed ID: 1805138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.